Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients

Psychoneuroendocrinology

Volumn 38, Issue 6, 2013, Pages 863-870

  Qi, Xin Rui ^a,b   Kamphuis, Willem ^a   Wang, Shanshan ^c   Wang, Qian ^d   Lucassen, Paul J ^d   Zhou, Jiang Ning ^b   Swaab, Dick F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anterior cingulate cortex; Bipolar disorder; Dorsolateral prefrontal cortex; Major depressive disorder; Mineralocorticoid receptor; Paraventricular nucleus

Indexed keywords

GLUCOCORTICOID RECEPTOR ALPHA; HORMONE RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR;

AGED; ANTERIOR CINGULATE; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MALE; MOOD DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

AGED; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION PROFILING; GYRUS CINGULI; HUMANS; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PREFRONTAL CORTEX; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID;

EID: 84877026896     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.09.014     Document Type: Article

References (39)

1. Anacker C., Zunszain P.A., Carvalho L.A., Pariante C.M. The glucocorticoid receptor: pivot of depression and of antidepressant treatment?. Psychoneuroendocrinology 2011, 36:415-425.
2. Almeida O.F., Conde G.L., Crochemore C., Demeneix B.A., Fischer D., Hassan A.H., Meyer M., Holsboer F., Michaelidis T.M. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J. 2000, 14:779-790.
3. Bao A.M., Swaab D.F. Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus. Vitam. Horm. 2010, 82:339-365.
4. Belanoff J.K., Rothschild A.J., Cassidy F., DeBattista C., Baulieu E.E., Schold C., Schatzberg A.F. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol. Psychiatry 2002, 52:386-392.
5. Bossers K., Wirz K.T., Meerhoff G.F., Essing A.H., van Dongen J.W., Houba P., Kruse C.G., Verhaagen J., Swaab D.F. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain 2010, 133:3699-3723.
6. Brinks V., Berger S., Gass P., de Kloet E.R., Oitzl M.S. Mineralocorticoid receptors in control of emotional arousal and fear memory. Horm. Behav. 2009, 56:232-238.
7. Budziszewska B., Lason W. Pharmacological modulation of glucocorticoid and mineralocorticoid receptors in the rat central nervous system. Pol. J. Pharmacol. 1994, 46:97-102.
8. Dedovic K., Duchesne A., Andrews J., Engert V., Pruessner J.C. The brain and the stress axis: the neural correlates of cortisol regulation in response to stress. Neuroimage 2009, 47:864-871.
9. de Kloet E.R., Derijk R.H., Meijer O.C. Therapy insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:168-179.
10. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct. Funct. 2008, 213:93-118.
11. Drevets W.C., Savitz J., Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 2008, 13:663-681.
12. Gass P., Reichardt H.M., Strekalova T., Henn F., Tronche F. Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for depression and anxiety?. Physiol. Behav. 2001, 73:811-825.
13. Glahn D.C., Curran J.E., Winkler A.M., Carless M.A., Kent J.W., Charlesworth J.C., Johnson M.P., Goring H.H., Cole S.A., Dyer T.D., Moses E.K., Olvera R.L., Kochunov P., Duggirala R., Fox P.T., Almasy L., Blangero J. High dimensional endophenotype ranking in the search for major depression risk genes. Biol. Psychiatry 2012, 71:6-14.
14. Hassan A.H., von Rosenstiel P., Patchev V.K., Holsboer F., Almeida O.F. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp. Neurol. 1996, 140:43-52.
15. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
16. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disord. 2001, 62:77-91.
17. Kamphuis W., Schneemann A., van Beek L.M., Smit A.B., Hoyng P.F., Koya E. Prostanoid receptor gene expression profile in human trabecular meshwork: a quantitative real-time PCR approach. Invest. Ophthalmol. Vis. Sci. 2001, 42:3209-3215.
18. Keller J., Flores B., Gomez R.G., Solvason H.B., Kenna H., Williams G.H., Schatzberg A.F. Cortisol circadian rhythm alterations in psychotic major depression. Biol. Psychiatry 2006, 60:275-281.
19. Kino T., Jaffe H., Amin N.D., Chakrabarti M., Zheng Y.L., Chrousos G.P., Pant H.C. Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor. Mol. Endocrinol. 2010, 24:941-952.
20. Klok M.D., Alt S.R., Irurzun Lafitte A.J., Turner J.D., Lakke E.A., Huitinga I., Muller C.P., Zitman F.G., Ronald de Kloet E., Derijk R.H. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J. Psychiatr. Res. 2011, 45:871-878.
21. Koenigs M., Huey E.D., Calamia M., Raymont V., Tranel D., Grafman J. Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression. J. Neurosci. 2008, 28:12341-12348.
22. Labonte B., Yerko V., Gross J., Mechawar N., Meaney M.J., Szyf M., Turecki G. Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and methylation in suicide completers with a history of childhood abuse. Biol. Psychiatry 2012, 72:41-48.
23. Lai M., Horsburgh K., Bae S.E., Carter R.N., Stenvers D.J., Fowler J.H., Yau J.L., Gomez-Sanchez C.E., Holmes M.C., Kenyon C.J., Seckl J.R., Macleod M.R. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur. J. Neurosci. 2007, 25:1832-1842.
24. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry 1998, 43:547-573.
25. Morse J.K., Davis J.N. Regulation of ischemic hippocampal damage in the gerbil: adrenalectomy alters the rate of CA1 cell disappearance. Exp. Neurol. 1990, 110:86-92.
26. Oitzl M.S., Champagne D.L., van der Veen R., de Kloet E.R. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci. Biobehav. Rev. 2010, 34:853-866.
27. Otte C., Hinkelmann K., Moritz S., Yassouridis A., Jahn H., Wiedemann K., Kellner M. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J. Psychiatr. Res. 2010, 44:339-346.
28. Raadsheer F.C., van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J., Tilders F.J., Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry 1995, 152:1372-1376.
29. Reul J.M., Stec I., Soder M., Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 1993, 133:312-320.
30. Rozeboom A.M., Akil H., Seasholtz A.F. Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:4688-4693.
31. Schule C., Baghai T.C., Eser D., Rupprecht R. Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression. Expert Rev. Neurother. 2009, 9:1005-1019.
32. Spencer R.L., Kim P.J., Kalman B.A., Cole M.A. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 1998, 139:2718-2726.
33. Swaab D.F., Fliers E., Hoogendijk W.J., Veltman D.J., Zhou J.N. Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. Prog. Brain Res. 2000, 126:369-396.
34. Van de Nes J.A., Kamphorst W., Ravid R., Swaab D.F. Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol. 1998, 96:129-138.
35. Wang Q., Joels M., Swaab D.F., Lucassen P.J. Hippocampal GR expression is increased in elderly depressed females. Neuropharmacology 2012, 62:527-533.
36. Wang S.S., Kamphuis W., Huitinga I., Zhou J.N., Swaab D.F. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol. Psychiatry 2008, 13:786-799. 741.
37. Xing G.Q., Russell S., Webster M.J., Post R.M. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. Int. J. Neuropsychopharmacol. 2004, 7:143-153.
38. Zennaro M.C., Keightley M.C., Kotelevtsev Y., Conway G.S., Soubrier F., Fuller P.J. Human mineralocorticoid receptor genomic structure and identification of expressed isoforms. J. Biol. Chem. 1995, 270:21016-21020.
39. Zhao J., Bao A.M., Qi X.R., Kamphuis W., Luchetti S., Lou J.S., Swaab D.F. Gene expression of GABA and glutamate pathway markers in the prefrontal cortex of non-suicidal elderly depressed patients. J. Affect. Disord. 2012, 138:494-502.